pamrevlumab - CISMeF

Preferred Label : pamrevlumab;

MeSH note : in phase 1 clinical trials (2010) for treating microalbuminuric diabetic kidney disease;

CISMeF synonym : FG 3019;

MeSH hyponym : FG3019; FG-3019;

Is substance : O;

UNII : QS5F6VTS0O;

Détails

Origin ID

C560078;

UMLS CUI

C5139936;

Currated CISMeF NLP mapping
- Pamrevlumab [NCIt concept]
MeSH term(s) associated for indexing
- antibodies, monoclonal [MeSH Descriptor]
- antibodies, monoclonal, humanized [MeSH Descriptor]
Record concept(s)
- FG 3019 [MeSH concept]
- pamrevlumab [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Pamrevlumab [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients